Skip to main content

About Crohn’s & Colitis Hub

A diagnosis of inflammatory bowel disease (IBD) can be an emotional time, especially with the lack of information about the condition among the general community. We have created a safe place; a credible source of information, your go-to place to turn to if you are looking for answers, read inspirational stories from people in the same situation as yours, explore ongoing research in the field, and much more. Crohn’s & Colitis Hub provides a comprehensive range of information and support to help people find the right information or service for their individual needs.

Nearly 85,000 Australians are living with inflammatory bowel disease, the collective term used for Crohn’s disease and ulcerative colitis, a gastrointestinal condition that affects any part of the gut, though the most common area affected is the end of the ileum or the colon.

Symptoms vary from person to person, and range from mild to severe and can change over time. Most common symptoms include diarrhoea, abdomen pain, loss of appetite, anaemia, joint pain and mouth ulcers.

Presently, there is no cure for IBD, and the exact cause is still unknown.To manage the condition, it is essential to develop know-how on the potential impact of living with the condition, managing IBD and information on overcoming everyday challenges associated with the condition.

Crohn’s & Colitis Hub’s resources will include news, articles, features and videos curated from all across the web, including medical journals, functioning as a one-stop website focusing on IBD and related issues.

For additional information on inflammatory bowel disease resources, contact Crohn’s & Colitis Australia at 1800 138 029.

The latest news and Research

Blog

Tips for surviving your first PillCam

Posted: January 25 2021

By Jenna Farmer Although inflammatory bowel disease (IBD) isn’t a new condition, the scientific developments surrounding it are constantly changing. Along with new treatments, new procedures have also been created to help with the diagnostic and monitoring process of IBD patients. One of these is a PillCam, a nifty piece of technology that’s particularly useful for those […]

Read more

Research

Early assessment with gastrointestinal ultrasound in patients hospitalised for a flare of ulcerative colitis

Predicting the need for salvage therapy: a pilot study

Approximately 30% of patients hospitalised with severe ulcerative colitis do not respond to corticosteroids, but the decision to introduce salvage therapy is delayed to at least the third day of treatment, according to the widely applied Oxford criteria to assess response. This pilot study aimed to determine if gastrointestinal ultrasound performed on admission can predict […]

Read more

Blog

Sugar may trigger inflammatory bowel disease by breaking down gut mucus

Posted: January 20 2021

By Madeline Barron When I was seventeen, I discovered that I could make s’mores in the microwave. The recipe was simple: slam a marshmallow on to a graham cracker, heat for 20 seconds, and let it balloon. This occasional summer treat soon became a daily indulgence. My inflammatory bowel disease (IBD) diagnosis soon followed.  IBD […]

Read more

Research

Vitamin D modulates intestinal microbiota in inflammatory bowel diseases

The main micronutrient deficiencies observed in patients with IBD are zinc, iron, vitamin B12, and vitamin D, contributing to a critical condition and influencing on well-being.

Inflammatory bowel disease (IBD) is a chronic inflammation of the gastrointestinal tract (GIT), including Crohn’s disease (CD) and ulcerative colitis (UC), which differ in the location and lesion extensions. Both diseases are associated with microbiota dysbiosis, with a reduced populationof butyrate-producing species, abnormal inflammatory response, and micronutrient deficiency (e.g., vitamin D hypovitaminosis). Vitamin D (VitD) […]

Read more

News

Potential preventative treatment demonstrated for Crohn’s disease

Posted: December 22 2020

By Jeff Hansen This research, led by University of Alabama at Birmingham researcher Charles O. Elson, M.D., professor of medicine, focused on a subset of T cells known as T memory, or Tm cells. The UAB researchers used a triple-punch treatment to remove Tm cells and increase the number of T regulatory, or Treg, cells. Both of these results were […]

Read more

News

IBD therapies not linked with adverse pregnancy outcomes

Posted: December 22 2020

Click for Video Link She said they found no association between biologic, thiopurine or combination therapy and adverse outcomes at birth or within the first year of life. Additionally, she said physicians should continue providing IBD medication throughout pregnancy.

Read more